# Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls

> **NCT07394309** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Continent Pharmaceutical Co, Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Liver Fibrosis

## Interventions

- **DRUG:** Hydronidone capsules

## Key facts

- **NCT ID:** NCT07394309
- **Lead sponsor:** Beijing Continent Pharmaceutical Co, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-15
- **Primary completion:** 2026-02-15
- **Final completion:** 2026-10-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07394309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07394309, "Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07394309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*